Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1807503-86-1
1951439-46-5
252378-69-1
1235514-18-7
1895922-75-4
1895922-74-3
147912-03-6 | M-Peg4-succinimidyl carbonate | AA019EBS | MFCD30828679
1352649-44-5 | TAMRA alkyne, 6-isomer | AA019EFY | MFCD29912898
848410-29-7 | 1-Methyloctahydro-1,6-naphthyridin-2(1H)-one hydrochloride | AA019EJA | MFCD29917044
1268121-69-2 | 2-(4-fluorobenzyl)succinic acid | AA019EMC | MFCD09835755
63113-45-1 | Dibenzo[c,f][1,2]thiazepin-11(6H)-one 5,5-dioxide | AA019EPL | MFCD28992014
885500-42-5 | 4,6-dichloro-N-ethylpyrimidin-5-amine | AA019ESO | MFCD20662829
371981-27-0 | (2-Piperidin-4-yl-phenyl)-methanol hydrochloride | AA019EVE | MFCD29075591
1588769-34-9 | 1,2,4]triazolo[1,5-a]pyridin-6-ylboronic acid | AA019EZA | MFCD18250334
82547-58-8 | Cefteram | AA019FSJ | MFCD00864913
374-04-9 | 2-Bromo-1,1,1-trifluoro-2-methyl-propane | AA019GD4 | MFCD20233106
124703-78-2